Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Isenberg

Showing results (491-500 of 519) with videos related to

Pageof 52
Sort By:
Scandinavian Journal of Immunology|November 1, 1989
Elevated IgG antibody levels to the mycobacterial 65-kDa heat shock protein are characteristic of patients with rheumatoid arthritisG Tsoulfa, G A Rook, G M Bahr, et al.
Arthritis and Rheumatism|January 1, 1997
Magnetic resonance imaging of the brain and cerebral proton spectroscopy in patients with systemic lupus erythematosusR J Chinn, I D Wilkinson, M A Hall-Craggs, et al.
Lancet (London, England)|July 30, 1988
Galactosylation of IgG associated oligosaccharidesD A Isenberg, P M Lydyard, J S Axford, et al.
The Journal of Rheumatology|February 11, 1999
Randomized clinical trials and longitudinal observational studies in systemic lupus erythematosus: consensus on a preliminary core set of outcome domainsJ S Smolen, V Strand, M Cardiel, et al.
Neurology|July 28, 2004
Polymyositis: an overdiagnosed entityF W Miller, L G Rider, P H Plotz, et al.
The Journal of Rheumatology|February 24, 2000
The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for Systemic Lupus Erythematosus International ComparisonD D Gladman, C H Goldsmith, M B Urowitz, et al.
Arthritis and Rheumatism|December 17, 2002
Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trialE H S Choy, D A Isenberg, T Garrood, et al.
Rheumatology (Oxford, England)|July 18, 2003
International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset diseaseD A Isenberg, E Allen, V Farewell, et al.
Lupus|May 29, 2012
Autoantibodies against galectin-2 peptides as biomarkers for the antiphospholipid syndromeC Janko, S André, L E Munoz, et al.
Arthritis and Rheumatism|May 1, 1997
The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosusD D Gladman, M B Urowitz, C H Goldsmith, et al.
Pageof 52

Showing results (491-500 of 519) with videos related to

Sort By:
Pageof 52
Scandinavian Journal of Immunology|November 1, 1989
Elevated IgG antibody levels to the mycobacterial 65-kDa heat shock protein are characteristic of patients with rheumatoid arthritisG Tsoulfa, G A Rook, G M Bahr, et al.
Arthritis and Rheumatism|January 1, 1997
Magnetic resonance imaging of the brain and cerebral proton spectroscopy in patients with systemic lupus erythematosusR J Chinn, I D Wilkinson, M A Hall-Craggs, et al.
Lancet (London, England)|July 30, 1988
Galactosylation of IgG associated oligosaccharidesD A Isenberg, P M Lydyard, J S Axford, et al.
The Journal of Rheumatology|February 11, 1999
Randomized clinical trials and longitudinal observational studies in systemic lupus erythematosus: consensus on a preliminary core set of outcome domainsJ S Smolen, V Strand, M Cardiel, et al.
Neurology|July 28, 2004
Polymyositis: an overdiagnosed entityF W Miller, L G Rider, P H Plotz, et al.
The Journal of Rheumatology|February 24, 2000
The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for Systemic Lupus Erythematosus International ComparisonD D Gladman, C H Goldsmith, M B Urowitz, et al.
Arthritis and Rheumatism|December 17, 2002
Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trialE H S Choy, D A Isenberg, T Garrood, et al.
Rheumatology (Oxford, England)|July 18, 2003
International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset diseaseD A Isenberg, E Allen, V Farewell, et al.
Lupus|May 29, 2012
Autoantibodies against galectin-2 peptides as biomarkers for the antiphospholipid syndromeC Janko, S André, L E Munoz, et al.
Arthritis and Rheumatism|May 1, 1997
The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosusD D Gladman, M B Urowitz, C H Goldsmith, et al.
Pageof 52